首页> 美国卫生研究院文献>Frontiers in Immunology >Genome-Wide Analysis Reveals Selective Modulation of microRNAs and mRNAs by Histone Deacetylase Inhibitor in B Cells Induced to Undergo Class-Switch DNA Recombination and Plasma Cell Differentiation
【2h】

Genome-Wide Analysis Reveals Selective Modulation of microRNAs and mRNAs by Histone Deacetylase Inhibitor in B Cells Induced to Undergo Class-Switch DNA Recombination and Plasma Cell Differentiation

机译:全基因组分析揭示了组蛋白脱乙酰基酶抑制剂对经历分类开关DNA重组和浆细胞分化的B细胞中microRNA和mRNA的选择性调节。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

As we have suggested, epigenetic factors, such as microRNAs (miRNAs), can interact with genetic programs to regulate B cell functions, thereby informing antibody and autoantibody responses. We have shown that histone deacetylase (HDAC) inhibitors (HDI) inhibit the differentiation events critical to the maturation of the antibody response: class-switch DNA recombination (CSR), somatic hypermutation (SHM), and plasma cell differentiation, by modulating intrinsic B cell mechanisms. HDI repress the expression of AID and Blimp-1, which are critical for CSR/SHM and plasma cell differentiation, respectively, in mouse and human B cells by upregulating selected miRNAs that silenced AICDA/Aicda and PRDM1/Prdm1 mRNAs, as demonstrated by multiple qRT-PCRs (J Immunol 193:5933–5950, 2014). To further define the selectivity of HDI-mediated modulation of miRNA and gene expression, we performed genome-wide miRNA-Seq and mRNA-Seq analysis in B cells stimulated by LPS plus IL-4 and treated with HDI or nil. Consistent with what we have shown using qRT-PCR, these HDI-treated B cells displayed reduced expression of Aicda and Prdm1, and increased expression of miR-155, miR-181b, and miR-361, which target Aicda, and miR-23b, miR-30a, and miR-125b, which target Prdm1. In B cells induced to undergo CSR and plasma cell differentiation, about 23% of over 22,000 mRNAs analyzed were expressed at a significantly high copy number (more than 20 copies/cell). Only 18 (0.36%) of these highly expressed mRNAs, including Aicda, Prdm1, and Xbp1, were downregulated by HDI by 50% or more. Further, only 16 (0.30%) of the highly expressed mRNAs were upregulated (more than twofold) by HDI. The selectivity of HDI-mediated modulation of gene expression was emphasized by unchanged expression of the genes that are involved in regulation, targeting, or DNA repair processes of CSR, as well as unchanged expression of the genes encoding epigenetic regulators and factors that are important for cell signaling or apoptosis. Our findings indicate that, in B cells induced to undergo CSR and plasma cell differentiation, HDI modulate selected miRNAs and mRNAs, possibly as a result of HDACs existing in unique contexts of HDAC/cofactor complexes, as occurring in B lymphocytes, particularly when in an activated state.
机译:正如我们所建议的,表观遗传因子,例如microRNA(miRNA),可以与遗传程序相互作用以调节B细胞功能,从而告知抗体和自身抗体应答。我们已经表明,组蛋白脱乙酰基酶(HDAC)抑制剂(HDI)通过调节内在B来抑制对抗体应答成熟至关重要的分化事件:类开关DNA重组(CSR),体细胞超突变(SHM)和浆细胞分化细胞机制。 HDI通过上调沉默AICDA / Aicda和PRDM1 / Prdm1 mRNA的选定miRNA来抑制小鼠和人类B细胞中分别对CSR / SHM和浆细胞分化至关重要的AID和Blimp-1表达, qRT-PCR(J Immunol 193:5933-5950,2014)。为了进一步定义HDI介导的miRNA调节和基因表达的选择性,我们在LPS加IL-4刺激并用HDI或nil刺激的B细胞中进行了全基因组miRNA-Seq和mRNA-Seq分析。与我们使用qRT-PCR显示的结果一致,这些经过HDI处理的B细胞显示出Aicda和Prdm1的表达减少,而靶向Aicda和miR-23b的miR-155,miR-181b和miR-361的表达增加。 ,靶向Prdm1的miR-30a和miR-125b。在诱导经历CSR和浆细胞分化的B细胞中,分析的22,000多种mRNA中约23%以明显高的拷贝数表达(每细胞超过20拷贝)。这些高表达的mRNA中只有18个(0.36%),包括Aicda,Prdm1和Xbp1,被HDI下调了50%或更多。此外,HDI仅上调(超过两倍)高度表达的mRNA中的16个(0.30%)。 HDI介导的基因表达调节的选择性通过参与CSR的调控,靶向或DNA修复过程的基因的不变表达以及编码表观遗传调控因子和重要因子的基因的不变表达来强调细胞信号传导或凋亡。我们的发现表明,在诱导经历CSR和浆细胞分化的B细胞中,HDI可以调节选定的miRNA和mRNA,这可能是因为HDAC存在于HDAC /辅因子复合物独特的环境中,尤其是在B淋巴细胞中,尤其是在激活状态。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号